A new U.S. study found that there are 10 natural compounds in pomegranates that may help to reduce the risk of estrogen-fueled breast cancer.
The chemicals in the pomegranate compunds block an enzyme associated with tumors called aromatase.
In a telephone interview, researcher Shiuan Chen, of the City of Hope cancer research and treatment center in Duarte, California said “We identified some of these chemicals in pomegranates that actually have properties that can suppress aromatase."
In fact, many breast cancer medicines come from a category of medications called aromatase inhibitors, including Aromasin, Femara, and Arimidex.
The chemicals in the pomegranate compunds block an enzyme associated with tumors called aromatase.
In a telephone interview, researcher Shiuan Chen, of the City of Hope cancer research and treatment center in Duarte, California said “We identified some of these chemicals in pomegranates that actually have properties that can suppress aromatase."
In fact, many breast cancer medicines come from a category of medications called aromatase inhibitors, including Aromasin, Femara, and Arimidex.
Posts
